NasdaqGS - Nasdaq Real Time Price • USD
Elevation Oncology, Inc. (ELEV)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.2 | -0.21 | -0.85 | -0.89 |
| Low Estimate | -0.23 | -0.26 | -0.92 | -1.3 |
| High Estimate | -0.18 | -0.18 | -0.76 | -0.62 |
| Year Ago EPS | -0.72 | -0.37 | -1.34 | -0.85 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.59 | -0.32 | -0.32 | -0.24 |
| EPS Actual | -0.72 | -0.37 | -0.25 | -0.19 |
| Difference | -0.13 | -0.05 | 0.07 | 0.05 |
| Surprise % | -22.00% | -15.60% | 21.90% | 20.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.2 | -0.21 | -0.85 | -0.89 |
| 7 Days Ago | -0.2 | -0.21 | -0.85 | -0.89 |
| 30 Days Ago | -0.2 | -0.21 | -0.85 | -0.89 |
| 60 Days Ago | -0.29 | -0.31 | -1.23 | -1.14 |
| 90 Days Ago | -0.28 | -0.3 | -1.17 | -1.07 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ELEV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 72.20% | -- | -- | 5.40% |
| Next Qtr. | 43.20% | -- | -- | 10.90% |
| Current Year | 36.60% | -- | -- | 4.50% |
| Next Year | -4.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/9/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 3/7/2024 |
| Maintains | Wedbush: Outperform to Outperform | 3/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
| Initiated | JMP Securities: Market Outperform | 3/1/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/20/2024 |
Related Tickers
CLSD Clearside Biomedical, Inc.
1.3400
+6.35%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
INAB IN8bio, Inc.
1.0400
0.00%
BCAB BioAtla, Inc.
2.5400
+12.89%
ACRV Acrivon Therapeutics, Inc.
8.46
-0.12%
IMVT Immunovant, Inc.
27.17
-2.09%
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
RZLT Rezolute, Inc.
2.6600
+2.31%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
TARA Protara Therapeutics, Inc.
2.9250
-4.10%